ERBB2 and breast cancer: Evidence from a HER2-driven mouse mammary tumor model supports a parallel model of evolution and also highlights the importance of mouse models in demonstrating that early disseminated tumor cells are critical to the formation of metastatic lesions (Hosseini et al., 2016).